Home > Press Room > Press Releases

Bioponic Phytoceuticals™ Chairman & CEO Steven M. Schorr discusses corporate plans and strategies in interviews on CEOCast.com and WallstreetReporter.com

MAUI, HAWAII, Date: August 1, 2006 /PRNewswire- 

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that its Chairman and CEO Steven M. Schorr is featured on both the CEOCast.com and WallstreetReporter.com investor relations web sites.

In two taped interviews aired beginning July 31, 2006, Mr. Schorr details the Company's innovative technology and discusses its successful branded product introductions into the $60 billion Complementary and Alternative Medicinal markets. He also discusses the Companyís entry into the biomedical research arena with its Curecumin™! product's use in research for a treatment for Childhood Hydrocephalus. Mr.Schorr then discusses the Company's strategy to bring its products into the marketplace and its value proposition for shareholder growth and returns.


CEOcast is an online investor relations web site dedicated to featuring interviews of CEOs at public companies. CEOcast's programming is distributed to millions of on-line investors at over 700 financial web sites, 20,000 portfolio managers at more than 3,300 North American institutions, and 7,000 investment research professionals representing over 425 institutions.

The WallStreet Reporter is a premier information source for professionals and features interviews with public company CEOs to more than 80,000 portfolio managers, analysts, venture capitalists, and 3,500 financial editors, reporters, and TV producers. Their website receives 4.5 million hits per month. "The opportunity to deliver our message to millions of potential investors about the Companyís innovative products, vast markets and our entry into the medical biotech arena is an important step in our investor relations program," said Steven M. Schorr, Chairman & CEO -Bioponic Phytoceuticals, Inc.

Bioponic Phytoceuticals™ is engaged in the formulation, production and distribution of Bioresonant Phytotherapeutic™ products for sale in the Complementary Alternative Medicine and natural products markets. The Company has developed a new patent pending healing modality "Bioresonant Phytotherapeutics™" and has several branded product lines currently in national distribution (including the noted natural nasal spray: Flight Spray®). www.bioponic.com, and www.flightspray.com

Contact: Steven M. Schorr, CEO
Bioponic Phytoceuticals
info@bioponic.com
phone: 808-876-1711

Certain statements contained in this press release are forward-looking statements within the meaning of federal securities laws.

NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. THE PINK SHEETS LLC DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.